Search

Management of masseter hypertrophy and bruxism with Botulinum Toxin A

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. The squaring of the lower third of the face can be an...

Periocular burns: a literature review of classification, management protocols and outcomes of treatment

The author provides a review of the current literature regarding the principles of classification, management protocols of acute ocular and periocular burns and the role of the burn and oculoplastic surgeon involved in their care. More than two-thirds of facial...

OPINION – Cosmetic surgery: a difficult reality with a simple solution

On 1 September 2022, an Independent Review released its long-awaited Report into Cosmetic Surgery in Australia [1]. Its key recommendation reflected the sentiment of our new, peer-reviewed, paper in the American Journal of Cosmetic Surgery entitled ‘Cosmetic Surgery Regulation in...

Skin biorevitalisation with hyaluronic acid

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. While Botulinum toxin A, dermal fillers, chemical peels and laser resurfacing are...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

A world-first in cosmetic surgery. All eyes are upon Australia.

The past three years have been tumultuous for cosmetic surgery in Australia. Media reporting on the poor practise of a small number of medical practitioners led to multiple administrative processes including the Independent review of the regulation of medical practitioners...